First-in-human circular RNA therapy for radiation-induced xerostomia
Data show unresectable patients becoming eligible for surgery
Personalised cancer vaccine with immunotherapy reduces melanoma recurrence after surgery
AI drug choices may cost millions
Base to Base biotech podcast 72: Cell-free DNA bioproduction
KTU chemists develop dual-action compounds to fight cancer
RSV antiviral drug receives FDA approval for phase II trial
Research uncovers new driver of immunotherapy resistance in pancreatic cancer
Pilot project between BioCytics and LIDE Biotech
IASO acquires cell therapy company MediSix
Jazz Pharmaceuticals to acquire Actio Biosciences and expand rare epilepsy portfolio
Tagomics introduces cfDNA-based blood test for multi-organ drug safety monitoring